Richard Lowenthal

1.2k total citations · 1 hit paper
16 papers, 949 citations indexed

About

Richard Lowenthal is a scholar working on Immunology and Allergy, Pharmacology and Physiology. According to data from OpenAlex, Richard Lowenthal has authored 16 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology and Allergy, 6 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Richard Lowenthal's work include Food Allergy and Anaphylaxis Research (7 papers), Allergic Rhinitis and Sensitization (6 papers) and Drug-Induced Adverse Reactions (4 papers). Richard Lowenthal is often cited by papers focused on Food Allergy and Anaphylaxis Research (7 papers), Allergic Rhinitis and Sensitization (6 papers) and Drug-Induced Adverse Reactions (4 papers). Richard Lowenthal collaborates with scholars based in United States, Canada and Japan. Richard Lowenthal's co-authors include Satoru Masamune, Atsushi Abiko, Barry Koplowitz, Shinya Harusawa, Robert A. Holton, Andrew Williams, Michael Kaliner, Enrique Carrazana, Barry E. Gidal and R. Edward Hogan and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

Richard Lowenthal

14 papers receiving 905 citations

Hit Papers

Asymmetric catalytic cyclopropanation of olefins: bis-oxa... 1990 2026 2002 2014 1990 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Lowenthal United States 8 756 227 102 77 60 16 949
Gabriele Fumagalli Italy 12 1.5k 1.9× 185 0.8× 130 1.3× 66 0.9× 6 0.1× 23 1.7k
Jaemoon Lee South Korea 17 417 0.6× 90 0.4× 212 2.1× 35 0.5× 2 0.0× 64 806
Gerd Rühter Germany 11 597 0.8× 66 0.3× 185 1.8× 28 0.4× 6 0.1× 13 890
Helen Feilden United Kingdom 9 195 0.3× 13 0.1× 196 1.9× 11 0.1× 16 0.3× 11 829
Satoshi Okuda Japan 15 437 0.6× 100 0.4× 232 2.3× 18 0.2× 3 0.1× 37 668
Chi‐An Huang Taiwan 14 513 0.7× 75 0.3× 66 0.6× 27 0.4× 22 735
Joshua M. Wieting United States 10 412 0.5× 118 0.5× 105 1.0× 14 0.2× 12 565
Sarah E. Morgan United Kingdom 10 98 0.1× 75 0.3× 45 0.4× 97 1.3× 4 0.1× 30 305
Masaki Meguro Japan 16 565 0.7× 164 0.7× 284 2.8× 22 0.3× 27 971
Zehong Wan United States 12 311 0.4× 102 0.4× 138 1.4× 31 0.4× 19 539

Countries citing papers authored by Richard Lowenthal

Since Specialization
Citations

This map shows the geographic impact of Richard Lowenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Lowenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Lowenthal more than expected).

Fields of papers citing papers by Richard Lowenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Lowenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Lowenthal. The network helps show where Richard Lowenthal may publish in the future.

Co-authorship network of co-authors of Richard Lowenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Lowenthal. A scholar is included among the top collaborators of Richard Lowenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Lowenthal. Richard Lowenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fleischer, David M., John Oppenheimer, David I. Bernstein, et al.. (2025). Pharmacokinetics of Epinephrine Nasal Spray under Various Conditions. Journal of Allergy and Clinical Immunology. 155(2). AB93–AB93.
2.
Lowenthal, Richard, et al.. (2024). Comparative Stability of Three Epinephrine Products Under Extreme Temperature Conditions. Journal of Allergy and Clinical Immunology. 153(2). AB371–AB371.
3.
Casale, Thomas B., et al.. (2023). Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection. Journal of Allergy and Clinical Immunology. 152(6). 1587–1596. 23 indexed citations
4.
Ebisawa, Motohiro, et al.. (2023). Rapid increases in epinephrine concentration following presumed intra–blood vessel administration via epinephrine autoinjector. SHILAP Revista de lepidopterología. 2(3). 100118–100118. 7 indexed citations
5.
Casale, Thomas B., et al.. (2023). Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care provider. The Journal of Allergy and Clinical Immunology In Practice. 12(2). 500–502.e1. 6 indexed citations
6.
Kaliner, Michael, et al.. (2022). Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly. Annals of Allergy Asthma & Immunology. 130(4). 508–514.e1. 22 indexed citations
7.
Ebisawa, Motohiro, et al.. (2022). Accidental Intravascular Auto-Injection of Epinephrine (Adrenaline) Rapidly Increases Pharmacokinetic and Hemodynamic Parameters. Journal of Allergy and Clinical Immunology. 149(2). AB4–AB4. 1 indexed citations
8.
Kaliner, Michael, et al.. (2020). Determination of the Effects of Active Seasonal Allergic Rhinitis Symptoms (Nasal Edema and Congestion) on the Absorption of Intranasal (IN) epinephrine Administered as ARS-1. Journal of Allergy and Clinical Immunology. 145(2). AB9–AB9. 1 indexed citations
9.
Lockey, Richard F., et al.. (2020). Comparison of the Pharmacokinetics and Pharmacodynamics of Epinephrine After Intranasal (IN), Intramuscular (IM) and Subcutaneous (SC) Administration in Three Landmark Studies. Journal of Allergy and Clinical Immunology. 145(2). AB78–AB78. 6 indexed citations
11.
Lowenthal, Richard, et al.. (2020). Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers. Clinical Pharmacology in Drug Development. 9(6). 719–727. 17 indexed citations
12.
Hogan, R. Edward, et al.. (2020). Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers. Epilepsia. 61(3). 455–464. 56 indexed citations
13.
Eerdekens, Mariëlle, et al.. (2000). 102. Kinetics and safety of a novel risperidone depot formulation. Biological Psychiatry. 47(8). S31–S31. 7 indexed citations
14.
Lowenthal, Richard & Satoru Masamune. (1991). Asymmetric copper-catalyzed cyclopropanation of trisubstituted and unsymmetrical cis-1,2-disubstituted olefins: modified bis-oxazoline ligands. Tetrahedron Letters. 32(50). 7373–7376. 241 indexed citations
15.
Lowenthal, Richard, Atsushi Abiko, & Satoru Masamune. (1990). Asymmetric catalytic cyclopropanation of olefins: bis-oxazoline copper complexes. Tetrahedron Letters. 31(42). 6005–6008. 456 indexed citations breakdown →
16.
Holton, Robert A., et al.. (1988). A synthesis of taxusin. Journal of the American Chemical Society. 110(19). 6558–6560. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026